ArticleOncology research2023

Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.

Juan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.